Sign in with Google
bearish
BioNote IPO Preview
240 Views16 Oct 2022 15:35
BioNote, a Korean company specializing in bio contents and animal diagnostics, is getting ready for an IPO in November. The IPO offering amount is from 234 billion won to 286 billion won.
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 11-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- ESR Group (1821 HK): Precondition Satisfied
- ESR (1821 HK): Pre-Cons Done. Scheme Doc By 22nd May
- FXI Rebalance Preview: Pop Mart (9992 HK) Pops Up Again
- CATL (3750 HK): Powered by the PetroDollar. HK Offer Overview and Valuations.
- [Japan Activism?] Toyota Group Equity Affiliate and Murakami Target Aichi Steel Does Large ToSTNeT-3
Top Unpaywalled Insights
More »- Bitcoin, Buffett, and the Barbarians at the Gate | Ep. #020 - The New Barbarians Podcast
- AQR DNA in a Digital World: Systematic Edge with Connor Farley - The New Barbarians Episode #019
- Curator's Cut: "Bubble" Tea, Japan M&A 🍿and TSMC from Different Lenses
- The Coming Global Trade Re-Ordering
- The Polycrisis Era (2025–2028): Navigating a World of Overlapping Disruptions
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Bionote: IPO Price Reduced Significantly & Bookbuilding Results12 Dec 2022
- Bionote IPO - Delayed Timeline & Updated Valuation Analysis14 Nov 2022
- BioNote IPO Valuation Analysis17 Oct 2022
- BioNote IPO Preview16 Oct 2022
- SD Biosensor (137310 KS): Aggressively Investing Windfall Gain From COVID; Adding New Growth Engines16 Oct 2022
- SD Biosensor: More Stringent Regulations for In-Vitro Diagnostics in Europe in 2022 & End of Lock-Up27 Sep 2021
- SD Biosensor IPO Valuation Analysis20 May 2021
x